Vous êtes sur la page 1sur 9

Cochrane Database of Systematic Reviews

Drug interventions for pain relief during orthodontic


treatment (Protocol)

Cooper JE, Harrison JE, Worthington HV

Cooper JE, Harrison JE, Worthington HV.


Drug interventions for pain relief during orthodontic treatment.
Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD003976.
DOI: 10.1002/14651858.CD003976.

www.cochranelibrary.com

Drug interventions for pain relief during orthodontic treatment (Protocol)


Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
TABLE OF CONTENTS
HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
WHAT’S NEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
HISTORY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6

Drug interventions for pain relief during orthodontic treatment (Protocol) i


Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Protocol]

Drug interventions for pain relief during orthodontic


treatment

James E Cooper1 , Jayne E Harrison1 , Helen V Worthington2

1 Orthodontic Department, Liverpool University Dental Hospital, Liverpool, UK. 2 Cochrane Oral Health Group, MANDEC, School
of Dentistry, The University of Manchester, Manchester, UK

Contact address: James E Cooper, Orthodontic Department, Liverpool University Dental Hospital, Pembroke Place, Liverpool, Mersey-
side, L3 5PS, UK. jamescooper@casualty.co.uk.

Editorial group: Cochrane Oral Health Group.


Publication status and date: Edited (no change to conclusions), published in Issue 1, 2009.

Citation: Cooper JE, Harrison JE, Worthington HV. Drug interventions for pain relief during orthodontic treatment. Cochrane
Database of Systematic Reviews 2003, Issue 1. Art. No.: CD003976. DOI: 10.1002/14651858.CD003976.

Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

ABSTRACT

This is the protocol for a review and there is no abstract. The objectives are as follows:

The aims of this review are to determine:

1) the effectiveness of drug interventions for pain relief during orthodontic treatment; and

2) whether there is a difference in the analgesic effect provided by different types, forms and doses of analgesia taken during orthodontic
treatment.

• functional appliances (braces that aim to move the teeth


BACKGROUND and modify the growth of the jaws. They can either be removable
from the mouth or fixed to the teeth during treatment).
Orthodontics is the area of dentistry concerned with the growth
of the jaws and face, the development of the teeth and the way
Orthodontic treatment may also involve the extraction of teeth to
the teeth and jaws bite together. It also involves the treatment
provide space to allow the teeth to be straightened and occasion-
of the teeth and jaws when they are irregular and/or bite in an
ally jaw surgery to correct the position of the jaws. Most patients
abnormal way. Orthodontics is usually carried out to improve the
undergoing orthodontic treatment are children or adolescents al-
functioning and appearance of the teeth. This may involve moving
though an increasing number of adults are seeking treatment.
teeth by applying a force to them via:
Treatment usually starts with the placement of the appliance, usu-
ally over two 30 to 45 minute visits. Routine adjustments are car-
• fixed appliances (braces where the components are attached ried out every 4 to 6 weeks over the course of treatment that lasts
to the teeth for the duration of the treatment); approximately 12 to 24 months. The removal of fixed appliances
takes about 30 to 45 minutes.
• removable appliances (braces that can be removed from the
mouth for cleaning during treatment); and/or Pain resulting from orthodontic treatment increases in proportion
Drug interventions for pain relief during orthodontic treatment (Protocol) 1
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
to the amount of force applied to the teeth. Different types of or- procedures associated with orthodontic treatment.
thodontic appliances (braces) may have an effect on the intensity
of the pain. Fixed orthodontic appliances seem to cause more pain
than functional appliances, which are used to help modify facial
OBJECTIVES
growth or removable braces (Sergl 1998). There is the acute pain
experience e.g. during or immediately after placement of separa- The aims of this review are to determine:
tors. Patients may also experience pain for 1 to 2 days (medium
term) following each adjustment appointment that occur every 4 1) the effectiveness of drug interventions for pain relief during
to 6 weeks. Pain may also be experienced acutely or continuously orthodontic treatment; and
in between adjustment visits (long term). 2) whether there is a difference in the analgesic effect provided
It is thought that the pain associated with orthodontic treatment by different types, forms and doses of analgesia taken during or-
is related to a reduction in the blood supply to the fibres that thodontic treatment.
attach the tooth to the surrounding bone. This happens when a
force is applied to the tooth via the brace. The reduction in blood
supply causes inflammation and the release of several chemicals METHODS
that greatly increase the transmission of painful stimuli (Proffit
2000).

Pain during orthodontic treatment has been shown to be the most Criteria for considering studies for this review
common reason for patients wanting to discontinue treatment and
was ranked as the worst aspect of the treatment (Oliver 1985).
Patients who underwent both premolar extractions and orthodon-
Types of studies
tic tooth movement experienced more pain 24 hours after initial
arch wire placement than 24 hours after tooth extraction (Jones All randomised and quasi-randomised controlled clinical trials re-
1992). When separators (small rubber bands that make space for lating to analgesia during orthodontic treatment.
metal orthodontic band attachments around the back teeth) are
placed between the teeth the pain gradually increases and peaks
the day after placement and then decreases. By 7 days the pain Types of participants
levels have decreased to the same level as 2 hours following treat- Trials will be eligible for inclusion in the review if they have re-
ment (Bernhardt 2001). The amount of pain experienced depends cruited participants receiving any type of orthodontic treatment.
upon the type of tooth movement occurring (tipping or bodily All age groups will be considered.
movement) and especially the pain threshold of the individual. It Trials assessing pain relief following tooth extraction or surgical
is likely that patients only require drug assisted pain relief for 2 to interventions, that are associated with orthodontics, will not be
3 days out of every 4 to 6 weeks so the long term implications of included.
the drug treatment are probably small.

Pain relief in dentistry has been fairly well studied in the literature
Types of interventions
but the management of pain associated with orthodontic treat-
ment is less well known. As clinicians we are often asked whether it
will be necessary for patients to take pain killers during orthodon-
tic treatment and if so which is likely to be the most effective. Some Active interventions
studies have shown that pre-treatment doses of non-steroidal anti- Local anaesthetic, any NSAID, paracetamol, opioid analgesics
inflammatory drugs may help to reduce the amount of pain ex- taken by any route, in any
perienced immediately after treatment (Steen Law 2000). How- dose, form or combination at any time following treatment or up
ever, there is some uncertainty among orthodontists as to which to 2 hours before
painkillers are most suitable and whether pre-emptive analgesia is treatment.
beneficial.

We will be investigating relief of pain arising during and after the


placement of orthodontic appliances. This may include one or Controls
more of the following: separators, fixed braces, removable braces, Maybe a placebo or another active intervention or the same inter-
headgear and during routine treatment to adjust appliances. We vention at a different dose or
will not include pain relief following tooth extraction or surgical taken at a different time.

Drug interventions for pain relief during orthodontic treatment (Protocol) 2


Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Types of outcome measures Search methods for identification of studies

Primary
Electronic searching
For the identification of studies included or considered for this re-
Patient reported pain intensity/pain relief measured on a visual
view detailed search strategies will be developed for each database
analogue scale and/or categorical scale.
searched. These will be based on the search strategy developed
Duration of pain.
for MEDLINE but revised appropriately for each database. The
search strategy will use a combination of controlled vocabulary
and freetext terms based on the search strategy for MEDLINE
Secondary (see Appendix 1), in conjunction with phases one and two of the
Cochrane sensitive search strategy for randomised controlled clin-
Dose and frequency of pain relief needed.
ical trials (RCTs) as published in the Cochrane Reviewers’ Hand-
Any rescue (alternative) pain relief taken/prescribed, including
book, Appendix 5c.
dose and time, following last treatment.
Adverse effects of painkillers e.g. total gastro-intestinal side effects.
Withdrawals from the study for any reason.
Failure to complete orthodontic treatment due to the pain expe- Databases to be searched
rienced. The following databases will be searched:
Visual analogue scales and any categorical outcomes will be trans- OHG Trials Register to current date;
formed into dichotomous data and analysed as such. Cochrane Pain, Palliative and Supportive Care Group Trials Reg-
ister to current date;
Cochrane Central Register of Controlled Trials (CENTRAL):
whole database at current issue;
Comparisons
MEDLINE 1966 - present;
1) Any analgesic at any dose taken at any time versus placebo at EMBASE 1980 - present;
any dose taken at any time. If there is evidence of effectiveness CINAHL 1982 - present.
further analysis of the class and type of drug will be undertaken;
2) Opioid of any type, at any dose taken at any time versus placebo
at any dose taken at any time; Handsearching
2.1) Subgroup analysis of type of opioid at any dose taken at any
time versus placebo at any dose taken at any time; A check will be made to see which journals have already been hand-
3) NSAID of any type, at any dose taken at any time versus placebo searched as part of the Oral Health Group’s handsearching pro-
at any dose taken at any time; gramme. The handsearching of the following journals will then be
3.1) Subgroup analysis of type of NSAID at any dose taken at any updated to the most current issue as appropriate: American Jour-
time versus placebo at any dose taken at any time; nal of Orthodontics and Dentofacial Orthopaedics; Angle Orthodon-
4) Paracetamol at any dose taken at any time versus placebo at any tist; European Journal of Orthodontics; Journal of Orthodontics; Aus-
dose taken at any time; tralian Journal of Orthodontics; Seminars in Orthodontics; Clinical
4.1) Subgroup analysis of type of paracetamol at any dose taken Orthodontics and Research.
at any time versus placebo at any dose taken at any time; If it appears, from searching the Cochrane Pain, Palliative and
5) Local anaesthetic at any dose given at any time versus placebo Supportive Care Group Trials Register, that relevant studies are
at any dose taken at any time; being found in non-orthodontic journals then these will be hand-
5.1) Subgroup analysis of type of local anaesthetic at any dose searched as necessary.
taken at any time versus placebo at any dose taken at any time. The bibliographies of the clinical trials identified will be checked
6) If there is evidence of effectiveness in any of the classes or for references to trials published outside the handsearched journals.
subgroups further analysis will be undertaken to determine the Personal references will be checked.
effectiveness and harms at different doses of opioid / NSAID /
paracetamol / local anaesthetic versus placebo.
7) Head to head comparisons of the best doses for each class and/ Language
or type of analgesic. Databases will be searched to include papers and abstracts pub-
8) Head to head comparisons of the best in each class and/or type lished in all languages and every effort will be made to translate
of analgesic. non-English papers.

Drug interventions for pain relief during orthodontic treatment (Protocol) 3


Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Unpublished studies Three main criteria will be examined:
The first named authors of all trial reports will be contacted in an a) allocation concealment recorded as adequate; unclear; inade-
attempt to identify unpublished studies and to obtain any further quate or not used as described in the Cochrane Reviewers’ Hand-
information about the trials. book;
b) blind outcome assessment;
c) completeness of follow up and intention-to-treat analysis.
Data collection and analysis
Data analysis
The Cochrane Collaboration statistical guidelines will be followed.
Study selection The data will be analysed by HW using RevMan and reported
Two review authors (James Cooper (JC) and Jayne Harrison (JH)) according to Cochrane Collaboration criteria.
will independently assess the title and abstract (when available) of Heterogeneity will be assessed using Cochran’s test and, if signifi-
all reports that are identified by the search strategy as being poten- cant heterogeneity is detected, the significance of treatment effects
tially relevant to the review. The full report will then be obtained will be assessed using the random-effects model. Clinical hetero-
for all studies that appear to meet the inclusion criteria or where geneity will be examined by assessing the types of participants,
there is insufficient information to make a clear decision or where the interventions, doses taken and timing and outcomes of each
there is disagreement between the review authors about eligibility. study. Data will only be pooled if there are studies of similar inter-
The full reports will then be assessed to establish which studies ventions taken by similar participants in similar doses at similar
do meet the inclusion criteria. Disagreements will be resolved by times.
discussion between JC and JH or the involvement of Helen Wor- Sensitivity analyses will be undertaken to examine the effect of
thington (HW). A record of all decisions made about the poten- allocation concealment, blind outcome assessment and complete-
tially eligible studies will be kept. The review authors will not be ness of follow up. The effect of including unpublished studies on
blind to trial author(s), institution or site of publication. Agree- the review’s findings will also be examined.
ment will be assessed using the Kappa statistic (Landis 1977). Risk ratio, the number needed to treat and corresponding 95%
confidence intervals will be calculated for dichotomous data. The
mean difference and 95% confidence intervals will be calculated
Data extraction
for continuous data.
Two review authors (JC and JH) will independently record the Analyses of subgroups identifying different drug treatments and
year of publication, interventions assessed, outcomes, sample size different doses will carried out. Differences between adult and
and age of subjects. HW will check the data extraction. child groups will be also be assessed.
The primary outcome will be the relief of pain. Harms (e.g. total
gastro-intestinal side effects) will be recorded and the results re-
ported in descriptive terms. Cross-over trials
All outcome data will be extracted. It will then be grouped into The treatment effects from cross-over trials will be combined with
those measured pre-treatment i.e. at baseline, < 1 hour, < 6 hours, those from parallel group trials where appropriate, using the pro-
< 12 hours, < 24 hours and < 48 hours following the orthodontic cedures outlined in Elbourne 2002. The methods of Follmann
procedure (placement or adjustment of appliance). If outcome 1992 will be used to estimate the appropriate standard errors if
data are reported at other time points then consideration will be these are not presented in the trial reports.
given to examining these as well.

Quality assessment
ACKNOWLEDGEMENTS
Two review authors (JC and JH) will undertake the quality assess-
ment of the included trials independently and in duplicate as part We would like to acknowledge the assistance of Sylvia Bickley (Tri-
of the data extraction process. Disagreements will be resolved by als Search Co-ordinator, Cochrane Oral Health Group) in devel-
discussion between JC and JH or the involvement of HW. oping the search strategy.

Drug interventions for pain relief during orthodontic treatment (Protocol) 4


Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
REFERENCES

Additional references Landis 1977


Landis JR, Koch GG. The measurement of observer
agreement for categorical data. Biometrics 1977;33(1):
Bernhardt 2001 159–74.
Bernhardt M, Southard KA, Batterson K, Logan HL,
Oliver 1985
Baker K, Jakobsen JR. The effect of pre-emptive and/
Oliver R, Knapman Y. Attitudes to orthodontic treatment.
or postoperative ibuprofen therapy for orthodontic
British Journal of Orthodontics 1985;12:179–88.
pain. American Journal of Orthodontics and Dentofacial
Orthopaedics 2001;120(1):20–7. Proffit 2000
Proffit WR, Fields HW Jr. Contemporary Orthodontics.
Elbourne 2002 Third Edition. St Louis, Missouri, USA: Mosby-Year Book,
Elbourne DR, Altman DG, Higgins JPT, Curtin F, Inc, 2000.
Worthington HV, Vail A. Meta-analyses involving cross- Sergl 1998
over trials: methodological issues. International Journal of Sergl H, Klages U, Zentner A. Pain and discomfort
Epidemiology 2002;31:140–9. during orthodontic treatment: causative factors and effects
on compliance. American Journal of Orthodontics and
Follmann 1992
Dentofacial Orthopaedics 1998;114(6):684–91.
Follmann D, Elliott P, Suh I, Cutler J. Variance imputation
for overviews of Clinical trials with continuous response. Steen Law 2000
Journal of Clinical Epidemiology 1992;42:769–73. Steen Law SL, Southard KA, Law AS, Logan HL, Jakobsen
JR. An evaluation of preoperative ibuprofen for the
Jones 1992 treatment of pain associated with orthodontic separator
Jones M, Chan C. Pain in the early stages of orthodontic placement. American Journal of Orthodontics and Dentofacial
treatment. Journal of Clinical Orthodontics 1992;26(5): Orthopaedics 2000;118(6):629–35.
311–3. ∗
Indicates the major publication for the study

APPENDICES

Appendix 1. MEDLINE (OVID) search strategy


#1 Explode ORTHODONTICS(ME)
#2 orthodontic*
#3 #1 OR#2
#4 PAIN (ME)
#5 FACIAL PAIN (ME)
#6 HEADACHE (ME)
#7 NEURALGIA (ME)
#8 EARACHE (ME)
#9 TOOTHACHE (ME)
#10 PAIN-MEASUREMENT (ME)
#11 pain* OR discomfort OR headache* OR migraine* OR neuralgi* OR earache* OR toothache Or odontalgi* OR (pain near
(manag* OR relief OR reliev OR control*))
#12 #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11
#13 Explode ANALGESICS (ME)
#14 analgesi*
#15 ANESTHETICS-LOCAL (ME)
#16 ((local OR topical) AND (anaesthetic* OR analgesi*)) OR ((local OR topical) AND (anesthetic* OR analgesi*))
#17 ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL (ME)
Drug interventions for pain relief during orthodontic treatment (Protocol) 5
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
#18 “Nonsteroidal Anti-Inflammatory Agent*” OR “Anti Inflammatory Agent*” OR “Nonsteroidal Antiinflammatory Agent*” OR
“Non Steroidal Antiinflammatory Agent” OR “Nonsteroidal Analgesic*” Or “Anti-Inflammatory” OR “Asprin-Like Agent*” or
NSAID*
#19 opioid
#20 aspirin
#21 paracetamol
#22 acetaminophen
#23 medication*
#24 #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 OR #22 OR #23
#25 #3 AND #12 AND #24

WHAT’S NEW

Date Event Description

18 September 2008 Amended Converted to new review format.

HISTORY
Protocol first published: Issue 1, 2003

CONTRIBUTIONS OF AUTHORS
The review was conceived by Jayne Harrison (JH). James Cooper (JC) and JH wrote the protocol. The review will be co-ordinated by
JC. JC, with the assistance of Sylvia Bickley (Trials Search Co-ordinator, Cochrane Oral Health Group), will develop the search strategy
and undertake the electronic searches. JC will undertake the handsearching. JC and JH will screen the search results and retrieved
papers, appraise the quality of the papers and abstract data from them. Helen Worthington will check the data extraction, undertake
the data analysis and assist with the interpretation of the data. JC and JH will write the review.

DECLARATIONS OF INTEREST
The participating reviewers declare that there is no financial conflict of interest and that they do not have any associations with industry
regarding the subject of this review.

SOURCES OF SUPPORT

Drug interventions for pain relief during orthodontic treatment (Protocol) 6


Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Internal sources
• The Royal Liverpool and Broadgreen Hospitals NHS Trust, UK.
• The University of Manchester, UK.

External sources
• No sources of support supplied

Drug interventions for pain relief during orthodontic treatment (Protocol) 7


Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Vous aimerez peut-être aussi